Agilon Health Inc. (AGL) Tops Q1 EPS by 3c ; Offers Guidance

Agilon Health Inc. (NYSE: AGL) reported Q1 EPS of $0.03, $0.03 better than the analyst estimate of $0.00. Revenue for the quarter came in at $1.53 billion versus the consensus estimate of $1.51 billion.

GUIDANCE:

Agilon Health Inc. sees Q2 2025 revenue of $1.43-1.5 billion, versus the consensus of $1.48 billion.

Agilon Health Inc. sees FY2025 revenue of $5.85-6.02 billion, versus the consensus of $5.91 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Coherus and Zumutor to run Phase 1 trial combining ZM008 and Loqtorzi